MA38162A1 - Pastille medicamenteuse a base d'ibuprofene sodique dihydrate - Google Patents

Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Info

Publication number
MA38162A1
MA38162A1 MA38162A MA38162A MA38162A1 MA 38162 A1 MA38162 A1 MA 38162A1 MA 38162 A MA38162 A MA 38162A MA 38162 A MA38162 A MA 38162A MA 38162 A1 MA38162 A1 MA 38162A1
Authority
MA
Morocco
Prior art keywords
sodium dihydrate
ibuprofen sodium
drug
lozenge based
drug lozenge
Prior art date
Application number
MA38162A
Other languages
English (en)
Other versions
MA38162B1 (fr
Inventor
Jean-François Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA38162(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MA38162A1 publication Critical patent/MA38162A1/fr
Publication of MA38162B1 publication Critical patent/MA38162B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet des pastilles médicamenteuses à sucer, de consistance solide pour se dissoudre dans la cavité buccale comprenant au moins l'ibuprofène sodique dihydraté comme principe actif, destinées au traitement des affections bucco-pharyngées.
MA38162A 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate MA38162B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (2)

Publication Number Publication Date
MA38162A1 true MA38162A1 (fr) 2016-12-30
MA38162B1 MA38162B1 (fr) 2019-12-31

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38162A MA38162B1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Country Status (17)

Country Link
US (1) US20160287514A1 (fr)
EP (1) EP2919752A1 (fr)
JP (1) JP6258342B2 (fr)
KR (1) KR20150084919A (fr)
CN (1) CN104780907A (fr)
AP (1) AP2015008515A0 (fr)
AU (1) AU2013346775B2 (fr)
BR (1) BR112015010808A2 (fr)
CA (1) CA2890832A1 (fr)
CL (1) CL2015001308A1 (fr)
FR (1) FR2997856B1 (fr)
MA (1) MA38162B1 (fr)
MX (1) MX2015006011A (fr)
RU (1) RU2015122217A (fr)
TN (1) TN2015000176A1 (fr)
WO (1) WO2014076203A1 (fr)
ZA (1) ZA201504280B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (fr) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Procédés de préparation de compositions curcuminoïdes
AU2020333973A1 (en) * 2019-08-22 2022-03-17 Applied Biological Laboratories, Inc. Compositions and methods using non-steroidal anti-inflammatory drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100198044B1 (ko) * 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
CA2570649A1 (fr) * 2004-06-07 2005-12-22 Strides Arcolab Limited Composition pharmaceutique renfermant une solution stable et claire de medicament anti-inflammatoire contenue dans une capsule gelatineuse molle, et procede de production correspondant
WO2006016126A1 (fr) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules compose de paracetamol a ains et d’un polyol fabrique par extrusion de matiere fondue
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2620219A1 (fr) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Formulations de doses orales d'ibuprofene organoleptiquement acceptables, procedes de preparation et d'utilisation de celles-ci
EP2020849A2 (fr) * 2006-05-26 2009-02-11 Auspex Pharmaceuticals Inc. Préparation et utilisation de composés substitués à base d'acide carboxylique
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
EP2919752A1 (fr) 2015-09-23
MA38162B1 (fr) 2019-12-31
CL2015001308A1 (es) 2015-08-28
CA2890832A1 (fr) 2014-05-22
BR112015010808A2 (pt) 2017-07-11
AU2013346775B2 (en) 2018-06-28
AU2013346775A1 (en) 2015-07-02
AP2015008515A0 (en) 2015-06-30
WO2014076203A1 (fr) 2014-05-22
TN2015000176A1 (fr) 2016-10-03
FR2997856A1 (fr) 2014-05-16
US20160287514A1 (en) 2016-10-06
FR2997856B1 (fr) 2015-04-24
ZA201504280B (en) 2017-09-27
MX2015006011A (es) 2015-09-10
JP6258342B2 (ja) 2018-01-10
KR20150084919A (ko) 2015-07-22
CN104780907A (zh) 2015-07-15
RU2015122217A (ru) 2017-01-10
JP2015537019A (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
EP2418945A4 (fr) Compositions de sel minéral/acide sulfonique et procédés d'utilisation
EP3003285A4 (fr) Forme dosifiée pharmaceutique solide de libération d'au moins un principe pharmaceutique actif dans la cavité buccale
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201071144A1 (ru) Гетероциклические производные
EA201270216A1 (ru) Фармацевтический состав
MA33939B1 (fr) 5-alcynyl-pyrimidines
EP2279003A4 (fr) Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires
MX2011007192A (es) Composicion farmaceutica.
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
EA201390394A1 (ru) Никотинсодержащий состав
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
MA38162A1 (fr) Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
MA34946B1 (fr) Nouvelles benzodioxolepipérazines
UY30021A1 (es) Formulación de suspensión de fexofenadina
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
EA201100287A1 (ru) Композиция ропинирола
EA201492271A1 (ru) Соединения хроманов
EP2865380A4 (fr) Application de lactone a d'inula linariifolia dans une préparation de médicament destiné au traitement de la myocardite
EA201490573A1 (ru) Соединение бензотиазолона
ECSP15030460A (es) Composición de difenidol de liberación prolongada
AR077915A1 (es) Forma cristalina de pemirolast
EP2910246A4 (fr) Composition pharmaceutique pour la prévention ou le traitement du cancer, contenant enoblock comme principe actif